Patents by Inventor Masaru Matsumoto

Masaru Matsumoto has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10943500
    Abstract: Provided are a method of on online test and an online test server for simply evaluating idea creation skills. A test is conducted online, in which a number of examinees are prompted to repeat a task of choosing a situation setting involving 5W1H from a plurality of options describing ideas corresponding to the situation setting as many times as possible within a time limit, and total scores are calculated for answers of the examinees by assigning weight according to predetermined criteria, thereby evaluating an innovation ability, such as an ability to create a lot of valuable ideas, an ability to create a variety of valuable ideas, or an ability to create rare valuable ideas.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: March 9, 2021
    Assignee: Visits Technologies Inc.
    Inventors: Masaru Matsumoto, Minoru Kuriyama, Ryoji Minami
  • Publication number: 20180286265
    Abstract: Provided are a method of on online test and an online test server for simply evaluating idea creation skills. A test is conducted online, in which a number of examinees are prompted to repeat a task of choosing a situation setting involving 5W1H from a plurality of options describing ideas corresponding to the situation setting as many times as possible within a time limit, and total scores are calculated for answers of the examinees by assigning weight according to predetermined criteria, thereby evaluating an innovation ability, such as an ability to create a lot of valuable ideas, an ability to create a variety of valuable ideas, or an ability to create rare valuable ideas.
    Type: Application
    Filed: February 8, 2017
    Publication date: October 4, 2018
    Inventors: Masaru MATSUMOTO, Minoru KURIYAMA, Ryoji MINAMI
  • Patent number: 8969298
    Abstract: An effective liquid preparation achieves high bioavailability (BA) of physiologically active peptides or proteins, including ghrelins, that are administered as drugs. Also provided is a method for improving the BA of physiologically active peptides or proteins, including ghrelins, that are subcutaneously injected in aqueous solutions. The liquid preparation contains: a physiologically active peptide or protein, such as ghrelins, as an active ingredient; an acid solution including one or a combination of two or more selected form the group consisting of acetic acid, lactic acid, phosphoric acid, glycine, citric acid, hydrochloric acid, propionic acid, butyric acid, benzoic acid and salts thereof; an alcohol; and a polar organic liquid including one or a combination of two or more selected from the group consisting of N-methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide and methylparaben.
    Type: Grant
    Filed: August 2, 2010
    Date of Patent: March 3, 2015
    Assignees: Daiichi Sankyo Co., Ltd.
    Inventors: Masaru Matsumoto, Masako Matsumoto, Takeshi Hanada, Naomi Wakabayashi
  • Patent number: 8802622
    Abstract: The invention provides a powdered composition for nasal administration, comprising a physiologically active peptide and cellulose acetate as the base, and having excellent nasal absorption for physiologically active peptides.
    Type: Grant
    Filed: March 18, 2011
    Date of Patent: August 12, 2014
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Masaru Matsumoto, Shuji Takeda, Kyohei Nobori
  • Patent number: 8518893
    Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 6 ?mol/mL.
    Type: Grant
    Filed: March 6, 2012
    Date of Patent: August 27, 2013
    Assignee: Asubio Pharma Co. Ltd.
    Inventors: Yoshiharu Minamitake, Masaru Matsumoto
  • Patent number: 8440628
    Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 6 ?mol/mL.
    Type: Grant
    Filed: July 25, 2007
    Date of Patent: May 14, 2013
    Assignee: Daiichi Sankyo Company, Limited
    Inventors: Yoshiharu Minamitake, Masaru Matsumoto
  • Publication number: 20130012439
    Abstract: The invention provides a powdered composition for nasal administration, comprising a physiologically active peptide and cellulose acetate as the base, and having excellent nasal absorption for physiologically active peptides.
    Type: Application
    Filed: March 18, 2011
    Publication date: January 10, 2013
    Applicant: Daiichi Sankyo Company, Limited
    Inventors: Masaru Matsumoto, Shuji Takeda, Kyohei Nobori
  • Publication number: 20120264691
    Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 6 ?mol/mL.
    Type: Application
    Filed: March 6, 2012
    Publication date: October 18, 2012
    Applicants: Kenji Kangawa, Daiichi Sankyo Company, Limited
    Inventors: Yoshiharu MINAMITAKE, Masaru Matsumoto
  • Patent number: 8207464
    Abstract: In a portable terminal, a plurality of operation keys 7 are formed in a key through hole, which is formed in a housing main body that covers a printed board 15, by partitioning a stainless steel sheet 26 (a key sheet) by slits 26a. A urethane sheet 28 is attached to the rear side of the stainless steel sheet 26, where the urethane sheet 28 has ridge portions 28a that bulge out through the slits 26a to the front side of the stainless steel sheet 26, and the rear sides of the ridge portions 28a have groove-like openings. A rubber layer 29 is attached to the rear side of the urethane sheet 28, where the rubber layer 29 has a plurality of protruding portions 23 that protrudes toward a substrate 25 at positions corresponding to a plurality of fixed contacts 16 over the substrate 25. LEDs (light emitting means) and a light guide sheet 21 are disposed closer to the substrate than the rubber layer 29 is.
    Type: Grant
    Filed: June 25, 2008
    Date of Patent: June 26, 2012
    Assignee: Sharp Kabushiki Kaisha
    Inventors: Masaru Matsumoto, Kimiaki Imai
  • Publication number: 20110077195
    Abstract: An effective liquid preparation achieves high bioavailability (BA) of physiologically active peptides or proteins, including ghrelins, that are administered as drugs. Also provided is a method for improving the BA of physiologically active peptides or proteins, including ghrelins, that are subcutaneously injected in aqueous solutions. The liquid preparation contains: a physiologically active peptide or protein, such as ghrelins, as an active ingredient; an acid solution including one or a combination of two or more selected form the group consisting of acetic acid, lactic acid, phosphoric acid, glycine, citric acid, hydrochloric acid, propionic acid, butyric acid, benzoic acid and salts thereof; an alcohol; and a polar organic liquid including one or a combination of two or more selected from the group consisting of N-methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide and methylparaben.
    Type: Application
    Filed: August 2, 2010
    Publication date: March 31, 2011
    Applicants: ASUBIO PHARMA CO., LTD., KENJI KANGAWA
    Inventors: Masaru Matsumoto, Masako Matsumoto, Takeshi Hanada, Naomi Wakabayashi
  • Publication number: 20100044203
    Abstract: In a portable terminal, a plurality of operation keys 7 are formed in a key through hole, which is formed in a housing main body that covers a printed board 15, by partitioning a stainless steel sheet 26 (a key sheet) by slits 26a. A urethane sheet 28 is attached to the rear side of the stainless steel sheet 26, where the urethane sheet 28 has ridge portions 28a that bulge out through the slits 26a to the front side of the stainless steel sheet 26, and the rear sides of the ridge portions 28a have groove-like openings. A rubber layer 29 is attached to the rear side of the urethane sheet 28, where the rubber layer 29 has a plurality of protruding portions 23 that protrudes toward a substrate 25 at positions corresponding to a plurality of fixed contacts 16 over the substrate 25. LEDs (light emitting means) and a light guide sheet 21 are disposed closer to the substrate than the rubber layer 29 is.
    Type: Application
    Filed: June 25, 2008
    Publication date: February 25, 2010
    Inventors: Masaru Matsumoto, Kimiaki Imai
  • Patent number: 7640005
    Abstract: An information protection system for a mobile terminal device, the information protection system including: an authentication device for performing a person authentication process when an information protection request for the mobile terminal device is issued in order to identify whether any person being subjected to authentication is an owner of the mobile terminal device by using a personal identity information, the mobile terminal device being capable of performing a predetermined information protection process in accordance with a remote operation information; and a management device for generating the remote operation information in order to perform an information protection process for the mobile terminal device and for transmitting the remote operation information to the mobile terminal device when the person authentication process by the authentication process device matches the personal identity information.
    Type: Grant
    Filed: April 18, 2006
    Date of Patent: December 29, 2009
    Assignee: Sharp Kabushiki Kaisha
    Inventors: Masaru Matsumoto, Hiroshi Tanaka
  • Publication number: 20080193997
    Abstract: An effective liquid preparation achieves high bioavailability (BA) of physiologically active peptides or proteins, including ghrelins, that are administered as drugs. Also provided is a method for improving the BA of physiologically active peptides or proteins, including ghrelins, that are subcutaneously injected in aqueous solutions. The liquid preparation contains: a physiologically active peptide or protein, such as ghrelins, as an active ingredient; an acid solution including one or a combination of two or more selected form the group consisting of acetic acid, lactic acid, phosphoric acid, glycine, citric acid, hydrochloric acid, propionic acid, butyric acid, benzoic acid and salts thereof; an alcohol; and a polar organic liquid including one or a combination of two or more selected from the group consisting of N-methyl-2-pyrrolidone, dimethylformamide, dimethylsulfoxide and methylparaben.
    Type: Application
    Filed: August 24, 2005
    Publication date: August 14, 2008
    Applicants: Kenji Kangawa, Asubio Pharma Co., Ltd.
    Inventors: Masaru Matsumoto, Masako Matsumoto, Takeshi Hanada, Naomi Wakabayashi
  • Publication number: 20080081787
    Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 6 ?mol/mL.
    Type: Application
    Filed: July 25, 2007
    Publication date: April 3, 2008
    Applicants: ASUBIO PHARMA CO., LTD
    Inventors: Yoshiharu Minamitake, Masaru Matsumoto
  • Patent number: 7138489
    Abstract: The present invention is a method for producing a peptide or a protein in which a side chain contains a modified amino acid residue, which comprises chemically producing a peptide fragment containing an amino acid residue having a modified side chain using an weak acid-cleavable resin, producing a peptide fragment containing no amino acid residue having a modified side chain using a genetic recombination method or/and an enzymatic method, and condensing the resulting two kinds of peptide fragments and, according to the present invention, a peptide or a protein containing modification such as acylation, glycosylation and phosphorylation can be obtained effectively and at high quality.
    Type: Grant
    Filed: April 10, 2003
    Date of Patent: November 21, 2006
    Assignee: Daiichi Asubio Pharma Co., Ltd.
    Inventors: Yoshiharu Minamitake, Masaru Matsumoto, Tomohiro Makino
  • Publication number: 20060234679
    Abstract: An information protection system for a mobile terminal device, the information protection system including: an authentication device for performing a person authentication process when an information protection request for the mobile terminal device is issued in order to identify whether any person being subjected to authentication is an owner of the mobile terminal device by using a personal identity information, the mobile terminal device being capable of performing a predetermined information protection process in accordance with a remote operation information; and a management device for generating the remote operation information in order to perform an information protection process for the mobile terminal device and for transmitting the remote operation information to the mobile terminal device when the person authentication process by the authentication process device matches the personal identity information.
    Type: Application
    Filed: April 18, 2006
    Publication date: October 19, 2006
    Applicant: Sharp Kabushiki Kaisha
    Inventors: Masaru Matsumoto, Hiroshi Tanaka
  • Publication number: 20060166871
    Abstract: It is provided a pharmaceutical composition stably containing ghrelin or its derivative, which is an endogenous growth hormone secretagogue (GHS) to a growth hormone secretagogue-receptor (GHS-R), comprising a aqueous solution containing the ghrelins having pH range of 2 to 7, wherein the aqueous solution having pH range of 2 to 7 is a buffer solution, especially, glycine hydrochloride buffer, acetate buffer, citrate buffer, lactate buffer, phosphate buffer, citric acid-phosphate buffer, phosphate-acetate-borate buffer or phthalate buffer, and the concentration of the ghrelins in the solution is from 0.03 nmol/mL to 61 ?mol/mL.
    Type: Application
    Filed: May 21, 2003
    Publication date: July 27, 2006
    Applicants: DAIICHI SUNTORY PHARMA., LTD., KENJI KANGAWA
    Inventors: Yoshiharu Minamitake, Masaru Matsumoto
  • Publication number: 20050131208
    Abstract: The present invention is a method for producing a peptide or a protein in which a side chain contains a modified amino acid residue, which comprises chemically producing a peptide fragment containing an amino acid residue having a modified side chain using an weak acid-cleavable resin, producing a peptide fragment containing no amino acid residue having a modified side chain using a genetic recombination method or/and an enzymatic method, and condensing the resulting two kinds of peptide fragments and, according to the present invention, a peptide or a protein containing modification such as acylation, glycosylation and phosphorylation can be obtained effectively and at high quality.
    Type: Application
    Filed: April 10, 2003
    Publication date: June 16, 2005
    Inventors: Yoshiharu Minamitake, Masaru Matsumoto, Tomohiro Makino
  • Patent number: 6528500
    Abstract: Described is an azole derivative represented by the following formula (1): wherein, R1 represents a substituted phenyl group, R2 and R3 each represents a fluorine atom, an alkyl group or the like, and R4 represents an alkyl group, or salt thereof; and a medicament comprising the derivative or salt as an effective ingredient. The compound according to the present invention exhibits excellent antimycotic action and has good aqueous solubility.
    Type: Grant
    Filed: September 28, 2000
    Date of Patent: March 4, 2003
    Assignee: SSP Co., Ltd.
    Inventors: Minoru Tokizawa, Hiromichi Eto, Kazuya Ishida, Kazunori Maebashi, Masaru Matsumoto, Takemitsu Asaoka, Susumu Sato
  • Patent number: 6362553
    Abstract: An object of the present invention is to provide a low cost, high performance, thin structure rotary motor for driving medium used in magnetic disk drive unit, optical disk drive unit or the like, in order to improve the productivity of terminating processing and the reliability of the coils. Magnetic materials which are divided to a plurality of blocks or divided corresponding to respective magnetic pole teeth are connected by means of thin portions. The respective magnetic pole teeth are wound continuously with wire without cutting the wire at the positions in which the thin portions are connected. When a stator is assembled, a plurality of blocks or magnetic pole teeth are disposed on a substrate by separating or bending the thin portions.
    Type: Grant
    Filed: December 23, 1998
    Date of Patent: March 26, 2002
    Assignee: Mitsubishi Denki Kabushiki Kaisha
    Inventors: Yuji Nakahara, Kenichi Azuma, Masaru Matsumoto, Youichi Fujita, Satoru Akutsu, Akira Hashimoto, Yasunori Takai, Tadashi Hasegawa, Hiroshi Miyazaki, Junji Kawada